Challenges of treating patients with chronic pain with dysphagia (CPD): physician and patient perspectives.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 24117419)

Published in Curr Med Res Opin on October 28, 2013

Authors

Joseph V Pergolizzi1, Robert Taylor, Srinivas Nalamachu, Robert B Raffa, Douglas R Carlson, Ravi K Varanasi, Ernest A Kopecky

Author Affiliations

1: Johns Hopkins University School of Medicine, Baltimore, MD, USA, Georgetown University School of Medicine, Washington, DC, USA, and Temple University School of Medicine , Philadelphia, PA , USA.

Associated clinical trials:

Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills | NCT03588806

Articles by these authors

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform (2008) 71.12

The role of autophagy in mitochondria maintenance: characterization of mitochondrial functions in autophagy-deficient S. cerevisiae strains. Autophagy (2007) 3.14

Genome-wide association study of alcohol dependence implicates a region on chromosome 11. Alcohol Clin Exp Res (2010) 2.99

Surgical intervention in childhood intermittent exotropia: current practice and clinical outcomes from an observational cohort study. Br J Ophthalmol (2012) 2.92

Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain (2013) 2.58

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract (2008) 2.45

Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst (2009) 2.34

Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study. Pain Med (2014) 2.09

Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain (2013) 1.89

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain (2012) 1.88

Autophagy and the degradation of mitochondria. Mitochondrion (2010) 1.75

Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract (2010) 1.53

Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system. Pain (2016) 1.39

Structure of the exosporium and sublayers of spores of the Bacillus cereus family revealed by electron crystallography. Mol Microbiol (2008) 1.35

Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status. Influenza Other Respir Viruses (2014) 1.35

Antidepressant use in black and white populations in the United States. Psychiatr Serv (2008) 1.33

Effects of low-load resistance training combined with blood flow restriction or hypoxia on muscle function and performance in netball athletes. J Sci Med Sport (2012) 1.32

The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria. Malar J (2008) 1.29

Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther (2008) 1.26

Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br J Clin Pharmacol (2011) 1.22

Surgical Care and Health Systems. World J Surg (2015) 1.16

Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey. Diabetes Metab Syndr Obes (2013) 1.10

The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations. Pharmacol Ther (2010) 1.07

Surface architecture of endospores of the Bacillus cereus/anthracis/thuringiensis family at the subnanometer scale. Proc Natl Acad Sci U S A (2011) 1.07

Global health conferences: are they truly "global"? The Bethune Round Table paradigm for promoting global surgery. Can J Surg (2011) 1.06

Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain. Curr Med Res Opin (2009) 1.05

Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory. Psychopharmacology (Berl) (2008) 1.04

Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians. Pharmacol Biochem Behav (2009) 1.03

Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States. J Pain Res (2013) 1.03

US flu mortality estimates are based on solid science. BMJ (2006) 1.02

Perspectives on the role of fospropofol in the monitored anesthesia care setting. Anesthesiol Res Pract (2011) 1.02

Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice. J Pharmacol Exp Ther (2003) 1.01

Use of the ODD-luciferase transgene for the non-invasive imaging of spontaneous tumors in mice. PLoS One (2011) 1.00

The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians. Eur J Pharmacol (2008) 0.97

An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol Biochem Behav (2007) 0.97

A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract (2012) 0.97

Influenza vaccination in elderly people. Lancet (2005) 0.96

Nicotine behavioral pharmacology: clues from planarians. Drug Alcohol Depend (2011) 0.95

Glutamate and aspartate measurements in individual planaria by rapid capillary electrophoresis. J Pharmacol Toxicol Methods (2010) 0.95

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations. Pain (2012) 0.95

First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians. Behav Pharmacol (2010) 0.94

Health status, function, productivity, and costs among individuals with idiopathic painful peripheral neuropathy with small fiber involvement in the United States: results from a retrospective chart review and cross-sectional survey. J Med Econ (2014) 0.94

Transversus abdominis block: clinical uses, side effects, and future perspectives. Pain Pract (2013) 0.94

Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression. J Clin Endocrinol Metab (2004) 0.93

Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine. Br J Pharmacol (2009) 0.92

Evaluation of the depth and duration of anesthesia from heated lidocaine/tetracaine (Synera) patches compared with placebo patches applied to healthy adult volunteers. Reg Anesth Pain Med (2010) 0.92

A nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria. Brain Res (2006) 0.91

New health care measures: emphasis on better management of postsurgical pain and postoperative nausea and vomiting. Hosp Pract (1995) (2014) 0.91

Dynamic risk factors in the misuse of opioid analgesics. J Psychosom Res (2012) 0.91

Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluation. Pain Med (2014) 0.91

Continuous multimechanistic postoperative analgesia: a rationale for transitioning from intravenous acetaminophen and opioids to oral formulations. Pain Pract (2011) 0.91

The improving outcomes in intermittent exotropia study: outcomes at 2 years after diagnosis in an observational cohort. BMC Ophthalmol (2012) 0.90

Randomized clinical evaluation of self-screening for anal cancer precursors in men who have sex with men. Cytojournal (2006) 0.90

Use of near-real-time medical claims data to generate timely vaccine coverage estimates in the US: the dynamics of PCV13 vaccine uptake. Vaccine (2013) 0.89

Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology (Berl) (2011) 0.88

Regional differences in quality of care and outcomes for the treatment of acute coronary syndromes: an analysis from the get with the guidelines coronary artery disease program. Crit Pathw Cardiol (2010) 0.88

Sucrose produces withdrawal and dopamine-sensitive reinforcing effects in planarians. Physiol Behav (2013) 0.88

Mercury in bats from the northeastern United States. Ecotoxicology (2013) 0.87

Mercury in breeding saltmarsh sparrows (Ammodramus caudacutus caudacutus). Ecotoxicology (2011) 0.87

Enzyme-based therapy for autism spectrum disorders -- is it worth another look? Med Hypotheses (2002) 0.87

Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting. J Clin Anesth (2012) 0.86

Measurement of glutamate and aspartate in Planaria. J Pharmacol Toxicol Methods (2005) 0.85

Diabetes self-management in a low-income population: impacts of social support and relationships with the health care system. Chronic Illn (2013) 0.85

Glucose control in critical illness using a web-based insulin dose calculator. Med Eng Phys (2007) 0.85

Heritability of level of response and association with recent drinking history in nonalcohol-dependent drinkers. Alcohol Clin Exp Res (2012) 0.85

On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data. Drug Alcohol Depend (2010) 0.85

Pain treatment in arthritis-related pain: beyond NSAIDs. Open Rheumatol J (2012) 0.85

Fixed-dose combinations for emerging treatment of pain. Expert Opin Pharmacother (2012) 0.84

Living with diabetes on Buffalo, New York's culturally diverse West Side. Chronic Illn (2012) 0.84

The tell-tale heart: Aspergillus fumigatus endocarditis in an immunocompetent patient. Hosp Pract (1995) (2013) 0.84

Effects of resistance training combined with vascular occlusion or hypoxia on neuromuscular function in athletes. Eur J Appl Physiol (2013) 0.84

Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies. Obesity (Silver Spring) (2011) 0.82

Role of pharmacogenetics in variable response to drugs: focus on opioids. Expert Opin Drug Metab Toxicol (2008) 0.82

Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain. J Pain Res (2012) 0.82

Toxicological evaluation and metal bioavailability in pregnant rats following exposure to clay minerals in the diet. J Toxicol Environ Health A (2004) 0.82

A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria. J Pharmacol Toxicol Methods (2004) 0.82

Proteomic Analysis of Soybean Roots under Aluminum Stress. Int J Plant Genomics (2011) 0.82

Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide. J Med Chem (2008) 0.82

Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations. Pain (2016) 0.82

Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain (2016) 0.81

A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain. Pain (2015) 0.81

Withdrawal-like behavior in planarians is dependent on drug exposure duration. Neurosci Lett (2008) 0.81

Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucose. Brain Res (2004) 0.81

Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. Pain Med (2003) 0.81

Validation of a three-factor measurement model of dyspnea in hospitalized adults with heart failure. Heart Lung (2011) 0.81

Histological versus clinical cirrhosis in chronic hepatitis C: does race/ethnicity really matter? Dig Dis Sci (2011) 0.81

Heritability of EEG coherence in a large sib-pair population. Biol Psychol (2007) 0.80

Differential behavioral effect of the TRPM8/TRPA1 channel agonist icilin (AG-3-5). Eur J Pharmacol (2007) 0.80

Planarians in pharmacology: parthenolide is a specific behavioral antagonist of cocaine in the planarian Girardia tigrina. Int J Dev Biol (2012) 0.80

Pentoxifylline, Ciprofloxacin and Dexamethasone Improve the Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients; Malignancy. Hematology (2000) 0.80

Involvement of the molecular chaperone Hspa5 in copper homeostasis in astrocytes. Brain Res (2012) 0.80

Agmatine: identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians. Synapse (2008) 0.80

The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients. J Manag Care Spec Pharm (2014) 0.80

Efficacy and tolerability of cyclobenzaprine extended release for acute muscle spasm: a pooled analysis. Postgrad Med (2010) 0.80